DM
NXTM

Deerfield Management’s NxStage Medical Inc. NXTM Stock Holding History

Deerfield Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,579,285
Closed -$43.6M – 111
2017
Q3 		$43.6M Sell
1,579,285
-2,254,045
-59% -$60.1M 1.96% 12
2017
Q2 		$96.1M Buy
3,833,330
+89,179
+2% +$2.21M 5.13% 3
2017
Q1 		$100M Sell
3,744,151
-514,045
-12% -$14.2M 3.87% 3
2016
Q4 		$112M Buy
4,258,196
+159,021
+4% +$3.93M 4.59% 2
2016
Q3 		$102M Sell
4,099,175
-406,293
-9% -$9.47M 4.76% 4
2016
Q2 		$97.7M Sell
4,505,468
-1,000,560
-18% -$17.9M 3.84% 2
2016
Q1 		$82.5M Buy
5,506,028
+917,028
+20% +$15.4M 3.51% 3
2015
Q4 		$101M Sell
4,589,000
-1,729,050
-27% -$32.2M 4.08% 2
2015
Q3 		$99.6M Buy
6,318,050
+545,000
+9% +$8.74M 3.85% 3
2015
Q2 		$82.5M Buy
5,773,050
+700,000
+14% +$11.9M 2.75% 4
2015
Q1 		$87.8M Buy
5,073,050
+261,556
+5% +$4.62M 2.84% 5
2014
Q4 		$86.3M Sell
4,811,494
-1,329,600
-22% -$21.4M 3.1% 7
2014
Q3 		$80.6M Buy
6,141,094
+1,241,373
+25% +$16.7M 2.94% 4
2014
Q2 		$70.4M Buy
4,899,721
+1,098,546
+29% +$14.3M 2.83% 7
2014
Q1 		$48.4M Sell
3,801,175
-1,769,464
-32% -$23.1M 1.98% 16
2013
Q4 		$55.7M Buy
5,570,639
+543,475
+11% +$6.17M 2.89% 7
2013
Q3 		$66.2M Buy
5,027,164
+1,117,250
+29% +$14.7M 3.08% 3
2013
Q2 		$55.8M Buy
+3,909,914
New +$49.2M 2.63% 6

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management's NXTM Position: Q4 2017 in Review

Deerfield Management sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 1,579,285 shares — an estimated $43.6M sold.

Deerfield Management first reported a position in NXTM in Q2 2013 and held it in 18 quarters. The position peaked at $112M in Q4 2016. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

  • Deerfield Management reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
  • Deerfield Management sold 1,579,285 NxStage Medical Inc. shares in Q4 2017, an estimated $43.6M.
  • Deerfield Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 18 quarters.
  • Deerfield Management's NxStage Medical Inc. position peaked at $112M in Q4 2016.
  • 178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on Deerfield Management's 13F filing for Q4 2017, filed 14 Feb 2018.